Policy Bites
India Pharma 2026: Government Pushes Shift from Generics to Biopharma Innovation
13 Apr 2026
Department of Pharmaceuticals DoPs
Showing 1-12 of 13 articles
Opinion
India’s Hypertension Treatment Needs Simpler Pathways
Prabhakaran Dorairaj, Centre for Chronic Disease Control; Ambuj Roy, AIIMS, New Delhi.
07 Apr 2026
Policy Bites
The Indo-Australian Biotech Bridge: Strategic Synergies in Clinical Trials
01 Apr 2026
Policy Bites
The Pharmacy of the World: A 2026 Overview of India’s Pharmaceutical Sector
22 Mar 2026
Opinion
The Next Frontier for India’s Defence Against Antimicrobial Resistance Is Governance, Not Just New Drugs
Sudha Chandrashekar, Health Systems Transformation Platform (HSTP); Shambhavi Nimisha Prasad, Kempegowda Institute of Medical Sciences (KIMS); Ramesh Masthi N R, Kempegowda Institute of Medical Sciences (KIMS) ...
13 Mar 2026
Policy Bites
Strengthening Self-Reliance in Active Pharmaceutical Ingredients
10 Mar 2026
Policy Bites
8th Jan Aushadhi Diwas – Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
07 Mar 2026
Opinion
When Breakthrough Cancer Care Meets India’s Policy Reality
Arpita Mukherjee, Independent immunologist and Biochemist
25 Feb 2026
Policy Bites
India’s MedTech Startups Urged to Go Global: Leveraging FTAs, Innovation Support and Global Market Access
13 Feb 2026
Policy Bites
Rajya Sabha Q&A: India’s Dependence on Imported APIs
03 Feb 2026
Policy Bites
Union Budget 2026-27: A Vision for Biopharmaceutical Sovereignty
01 Feb 2026
Policy Bites
Clean Governance Push: SCDPM 4.0 Under Department of Pharmaceuticals Leads Record-Management & Scrap Disposal Reforms
15 Sept 2025
Rethinking Public Policy Through Insight | Inquiry | Impact
Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs
An independent platform that connects research and public policy through clear, evidence-based communication, guided by an apolitical, non-partisan ethos.